| Product revenues | 232.63M |
| Cost of sales | 155.93M |
| Gross margin | 76.69M |
| Research and development | 19.75M |
| Research and development reimbursements | |
| Net research and development expenses | |
| Acquisition transaction expenses | 22K |
| Selling, general and administrative | 29.51M |
| Total operating expenses | 49.28M |
| Operating income | 27.42M |
| Interest income (expense) | -660K |
| Debt retirement expense | |
| Revaluation of derivatives | 0 |
| Foreign currency gain | |
| Loss from equity investment | |
| Other income | 359K |
| Earnings before income tax | |
| Income tax expense | 6.02M |
| Net income | 20.22M |
| Loss attributable to non-controlling interest | |
| Net income attributable to Amerigon, Inc. | |
| Convertible preferred stock dividends | |
| Net income (loss) attributable to common shareholders | |
| Basic earnings (loss) per share | 0.55 |
| Diluted earnings (loss) per share | 0.55 |
| Weighted average number of shares - basic | 36.48M |
| Weighted average number of shares - diluted | 36.59M |